Literature DB >> 10679936

Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.

W Lissens1, L De Meirleir, S Seneca, I Liebaers, G K Brown, R M Brown, M Ito, E Naito, Y Kuroda, D S Kerr, I D Wexler, M S Patel, B H Robinson, A Seyda.   

Abstract

Defects in the pyruvate dehydrogenase (PDH) complex are an important cause of primary lactic acidosis, a frequent manifestation of metabolic disease in children. Clinical symptoms can vary considerably in patients with PDH complex deficiencies, and almost equal numbers of affected males and females have been identified, suggesting an autosomal recessive mode of inheritance of the disease. However, the great majority of PDH complex deficiencies result from mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1). The major factors that contribute to the clinical variation in E1alpha deficiency and its resemblance to a recessive disease are developmental lethality in some males with severe mutations and the pattern of X-inactivation in females. To date, 37 different missense/nonsense and 39 different insertion/deletion mutations have been identified in the E1alpha subunit gene of 130 patients (61 females and 69 males) from 123 unrelated families. Insertion/deletion mutations occur preferentially in exons 10 and 11, while missense/nonsense mutations are found in all exons. In males, the majority of missense/nonsense mutations are found in exons 3, 7, 8 and 11, and three recurrent mutations at codons R72, R263 and R378 account for half of these patients with missense/nonsense mutations (25 of 50). A significantly lower number of females is found with missense/nonsense mutations (25). However, 36 females out of 55 affected patients have insertion/deletion mutations. The total number of female and male patients is thus almost the same, although a difference in the distribution of the type of mutations is evident between both sexes. In many families, the parents of the affected patients were studied for the presence of the PDHA1 mutation. The mutation was never present in the somatic cells of the father; in 63 mothers studied, 16 were carriers (25%). In four families, the origin of the new mutation was determined to be twice paternal and twice maternal. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679936     DOI: 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  54 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  ATP6AP2/(pro)renin receptor contributes to glucose metabolism via stabilizing the pyruvate dehydrogenase E1 β subunit.

Authors:  Atsuhiro Kanda; Kousuke Noda; Susumu Ishida
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

3.  Development of subdural effusions in association with pyruvate dehydrogenase deficiency.

Authors:  Maria Raissaki; Olga Grafakou; Andreas Giannopoulos; Martha Spilioti; Richard Rodenburg; Jan Smeitink; Athanasios Evangeliou; Nicholas Gourtsoyiannis
Journal:  Eur Radiol       Date:  2005-04-02       Impact factor: 5.315

4.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

5.  A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate.

Authors:  Zongchao Han; Kristen Berendzen; Li Zhong; Ira Surolia; Nitin Chouthai; Weihong Zhao; Njeri Maina; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2008-02-21       Impact factor: 4.797

6.  Four novel PDHA1 mutations in pyruvate dehydrogenase deficiency.

Authors:  E Ostergaard; L Birk Moller; H Serap Kalkanoglu-Sivri; A Dursun; M Kibaek; T Thelle; E Christensen; M Duno; F Wibrand
Journal:  J Inherit Metab Dis       Date:  2009-06-11       Impact factor: 4.982

7.  A novel Y243S mutation in the pyruvate dehydrogenase El alpha gene subunit: correlation with thiamine pyrophosphate interaction.

Authors:  C Benelli; F Fouque; I Redonnet-Vernhet; M Malgat; D Fontan; C Marsac; R Dey
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

8.  A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment.

Authors:  Lelanie Marais; Suzél M Hattingh; Dan J Stein; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2009-10-16       Impact factor: 3.584

9.  Pyruvate dehydrogenase phosphatase 1 (PDP1) null mutation produces a lethal infantile phenotype.

Authors:  J M Cameron; M Maj; V Levandovskiy; C P Barnett; S Blaser; N Mackay; J Raiman; A Feigenbaum; A Schulze; B H Robinson
Journal:  Hum Genet       Date:  2009-01-30       Impact factor: 4.132

10.  Solution structure and characterisation of the human pyruvate dehydrogenase complex core assembly.

Authors:  S Vijayakrishnan; S M Kelly; R J C Gilbert; P Callow; D Bhella; T Forsyth; J G Lindsay; O Byron
Journal:  J Mol Biol       Date:  2010-03-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.